Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00966979 · ClinicalTrials.gov registry record · NA
Triathlon® Partial Knee Replacement (PKR) Outcomes Study
A NA study, sponsored by Stryker Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 111
- Enrollment target
NCT00966979: Clinical Trial NA study, sponsored by Stryker Orthopaedics.
NCT00966979 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 111 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00966979, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the 10-year Knee Society Score (KSS) functional results of the Triathlon PKR Unicondylar Knee to the 10-year Knee Society Score (KSS) functional results of the Triathlon Cruciate Retaining (CR) Total Knee.
Primary Outcome
The Knee Society Score (KSS) consists of two distinct sub-scores: one for pain, range of motion, joint stability and alignment (Pain/Motion KSS) and one for distance walked, stair climbing and walking aids (Functional KSS). This outcome measure was only for the KSS Function Score at 10-years. The KSS Function score subscale is 0-100, with 100 representing a better outcome. Although the specific scores are not distinguished as "excellent", "good", "fair", or "poor", a higher value represents a b
Interventions
- DEVICE Triathlon PKR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2010-01 |
| Est. Completion | 2023-05 |
| Phase | NA |
Why NCT00966979 stopped before completion
NCT00966979 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Triathlon PKR is the first listed.
NCT00966979 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00966979 about?
NCT00966979 is a clinical study titled "Triathlon® Partial Knee Replacement (PKR) Outcomes Study". The purpose of this study is to compare the 10-year Knee Society Score (KSS) functional results of the Triathlon PKR Unicondylar Knee to the 10-year Knee Society Score (KSS) functional results of the Triathlon Cruciate Retaining (CR) Total Knee.
What is the current status of trial NCT00966979?
This trial is currently terminated. It is a NA study. The enrollment target is 111 participants. The study started on 2010-01. Estimated completion is 2023-05.
What interventions are being tested in trial NCT00966979?
The interventions under investigation include: Triathlon PKR (DEVICE).
Who is sponsoring clinical trial NCT00966979?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00966979's enrollment target sits among peer trials
111 816th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia